Alternative targeted therapy for early Her2 positive breast cancer.
Publication
, Journal Article
Harvey, SL; Khasraw, M
Published in: Gland Surg
February 2013
Duke Scholars
Published In
Gland Surg
DOI
ISSN
2227-684X
Publication Date
February 2013
Volume
2
Issue
1
Start / End Page
42 / 45
Location
China (Republic : 1949- )
Citation
APA
Chicago
ICMJE
MLA
NLM
Harvey, S. L., & Khasraw, M. (2013). Alternative targeted therapy for early Her2 positive breast cancer. Gland Surg, 2(1), 42–45. https://doi.org/10.3978/j.issn.2227-684X.2013.02.06
Harvey, Sandra L., and Mustafa Khasraw. “Alternative targeted therapy for early Her2 positive breast cancer.” Gland Surg 2, no. 1 (February 2013): 42–45. https://doi.org/10.3978/j.issn.2227-684X.2013.02.06.
Harvey SL, Khasraw M. Alternative targeted therapy for early Her2 positive breast cancer. Gland Surg. 2013 Feb;2(1):42–5.
Harvey, Sandra L., and Mustafa Khasraw. “Alternative targeted therapy for early Her2 positive breast cancer.” Gland Surg, vol. 2, no. 1, Feb. 2013, pp. 42–45. Pubmed, doi:10.3978/j.issn.2227-684X.2013.02.06.
Harvey SL, Khasraw M. Alternative targeted therapy for early Her2 positive breast cancer. Gland Surg. 2013 Feb;2(1):42–45.
Published In
Gland Surg
DOI
ISSN
2227-684X
Publication Date
February 2013
Volume
2
Issue
1
Start / End Page
42 / 45
Location
China (Republic : 1949- )